The use of pharmacotherapies for smoking cessation during pregnancy

Tobacco Control

Volumn 9, Issue SUPPL. 3, 2000, Pages

  Benowitz, Neal L ^a   Whiteside Jr , H Pennington ^c   Yaffe, Sumner ^j   Dempsey, Delia A ^b   Goldenberg, Robert L ^c   Hughes, John R ^d   Dolan Mullen, Patricia ^e   Ogburn, Paul L ^f   Oncken, Cheryl ^g   Orleans, C Tracy ^h   Slotkin, Theodore A ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^f MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^h ROBERT WOOD JOHNSON FOUNDATION   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NORTRIPTYLINE;

ARTICLE; EDUCATION; FEMALE; HEALTH PROMOTION; HUMAN; PREGNANCY; PRENATAL CARE; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BUPROPION; EDUCATION; FEMALE; HEALTH PROMOTION; HUMANS; NORTRIPTYLINE; PREGNANCY; PRENATAL CARE; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0033642782     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mullen PD. Maternal smoking during pregnancy and evidence-based intervention to promote cessation. In: Spangler JG, ed. Primary care: clinics in office practice. Philadelphia: WB Saunders, 1999;26:577-89.
2. Marks JS, Koplan JP, Hogue CJR, et al. A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women. Am J Prev Med 1990;6:282-91.
3. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29:1422-31.
4. Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 1998;285:931-45.
5. Levin ED, Slotkin TA. Developmental neurotoxicity of nicotine. In: Slikker W, Chang LW, eds. Handbook of developmental neurotoxicology. San Diego: Academic Press, 1998:587-615.
6. Roy TS, Andrews JE, Seidler FJ, et al. Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther 1998;287:1135-44.
7. Slotkin TA. The impact of fetal nicotine exposure on nervous system development and its role in sudden infant death. In: Benowitz NL, ed. Nicotine safety and toxicity. New York: Oxford University Press, 1998:89-97.
8. Smoking Cessation Clinical Practice Guideline Panel and Staff. The Agency for Health Care Policy and Research smoking cessation clinical practice guideline IS. JAMA 1996;275:1270-80.
9. Wright LN, Thorp JM, Kuller JA, et al. Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects. Am J Obstet Gynecol 1997;176:1090-1.
10. Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals. Thorax 1998;53:S1-38.
11. Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in pharmacotherapy of smoking. JAMA 1999;281:72-6.
12. Benowitz NL. Nicotine replacement therapy during pregnancy. JAMA 1991;266:3174-7.
13. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 5th ed. Baltimore: Williams & Wilkins, 1998:xxii.
14. Medical Economics Company. Physicians' desk reference? 54th ed. Montvale, New Jersey: Medical Economics Company, 2000:1690.
15. Benowitz NL. Summary: risks and benefits of nicotine. In: Benowitz NL, ed. Nicotine safety and toxicity. New York: Oxford University Press, 1998:185-94.
16. Wisborg K, Jespersen L, Henriksen TB, et al. Nicotine patches to pregnant smokers - a randomized study. Presentation: The First International Conference of the Society for Research on Nicotine and Tobacco. Copenhagen, Denmark, August 23, 1998.
17. Oncken CA, Hatsukami DK, Lupo VR, et al. Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther 1996;59:654-61.
18. Oncken CA, Hardardottir H, Hatsukami DK, et al Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics. Obstet Gynecol 1997;90:569-74.
19. Ogburn PL, Hurt RD, Croghan IT, et al Nicotine patch use in pregnant smokers-nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol 1999;181:736-43.
20. Joseph AM, Norman SM, Ferry, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-8.